TCDA

Tricida Stock Price

4.08
-0.01 (-0.24%)
Upgrade to Real-Time
Afterhours (Closed)
4.08

Low
3.61

52 Week Range

High
15.96

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Tricida Inc TCDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.24% 4.08 00:00:02
Open Price Low Price High Price Close Price Prev Close
3.9854 3.9854 4.18 4.08 4.09
Bid Price Ask Price Spread News
3.60 4.20 0.60 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,635 100,080 $ 4.12 $ 412,328 - 3.61 - 15.96
Last Trade Time Type Quantity Stock Price Currency
17:19:14 formt 1,321 $ 4.08 USD

Period:

Draw Mode:

Tricida Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 205.11M 50.27M 28.96M $ - $ - -5.29 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 676.83k 2.60%

more financials information »

Tricida News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TCDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.344.403.934.09317,402-0.26-5.99%
1 Month4.404.483.614.09280,735-0.32-7.27%
3 Months4.185.413.614.56372,991-0.10-2.39%
6 Months6.898.163.615.31529,787-2.81-40.78%
1 Year14.0415.963.617.22770,016-9.96-70.94%
3 Years23.4744.303.6117.08453,041-19.39-82.62%
5 Years25.0044.303.6117.32450,657-20.92-83.68%

Tricida Description

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.


Your Recent History
NASDAQ
TCDA
Tricida
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.